The Online Investor

Slideshow IPOs

By The Online Investor Staff, updated Tue., Dec. 6, 9:09 AM

Slide #1. Acrivon Therapeutics, Inc. Initial Public Offering

Company: Acrivon Therapeutics, Inc.
Proposed Symbol: ACRV
Shares Offered: 7,550,000
Price Per Share: $12.50
Over-Allotment: 1,132,500
Description: Acrivon Therapeutics, Inc. ("Acrivon" or "Acrivon Therapeutics") (Nasdaq: ACRV), a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proprietary proteomics-based patient responder identification platform, today announced the pricing of its initial public offering of 7,550,000 shares of common stock at a public offering price of $12.50 per share. In addition, Acrivon has granted the underwriters a 30-day option to purchase up to an additional 1,132,500 shares of common stock at the initial public offering price, less underwriting discounts and commissions. In addition to the shares sold in the initial public offering, Acrivon announced a concurrent sale of 400,000 shares of common stock at the public offering price per share in a private placement to Chione Limited, an existing stockholder of Acrivon. The sale of the shares of common stock in the private placement will not be registered under the Securities Act of 1933, as amended. The gross proceeds to Acrivon from the initial public offering and the concurrent private placement, without giving effect to the underwriters' option to purchase additional shares and before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $99.4 million. All of the shares of common stock are being offered by Acrivon. Acrivon's shares are expected to begin trading on the Nasdaq Global Market on November 15, 2022 under the ticker symbol "ACRV." The offering is expected to close on November 17, 2022, subject to customary closing conditions.

IPOs: Acrivon Therapeutics, Inc.

List of IPOs in this Slideshow: Company Ticker IPO Date Shuttle Pharmaceuticals Holdings, Inc. SHPH Yoshiharu Global Co. YOSH Wearable Devices Ltd. WLDS LINKBANCORP, Inc. LNKB Nexalin Technology, Inc. NXL Qomolangma Acquisition Corp. QOMO Laser Photonics Corporation LASE Aquaron Acquisition Corp. AQUNU TenX Keane Acquisition TENKU Hudson Acquisition I Corp. HUDU Snail, Inc. SNAL Plutonian Acquisition Corp. PLTN ASP Isotopes Inc. ASPI Atour Lifestyle Holdings Limited ATAT Acrivon Therapeutics, Inc. ACRV

IPOs Page |

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.